States Target Pharmacy Benefit Managers to Address Drug Prices
To tackle the escalating drug prices in the U.S., state legislators are focusing on pharmacy benefit managers (PBMs). Actions taken include a ban in Arkansas and a restrictive measure in Indiana. However, these efforts seem unlikely to actually lower drug costs. As a result, the impact could primarily hit Americans with disabilities, who may suffer the most from these changes.
For many individuals living with disabilities or chronic conditions, local pharmacies represent more than just a place to collect medications. They serve as essential healthcare hubs, often the most reliable access points in a system that can be quite fragmented.
There are a few critical points that policymakers need to consider: drug prices are excessively high, access is inadequate, and these issues intersect particularly harshly for Americans with disabilities.
Measures that hinder pharmacies do not truly protect consumers. Instead, they create obstacles for the very patients they are meant to support.
The Importance of Proximity
Healthy adults can switch pharmacies without much hassle. But for individuals with disabilities, that’s not an option. They often depend on established relationships with nearby pharmacies for managing complex medication regimens, limited transport, and situations requiring in-person assistance.
For instance, someone with epilepsy juggling various medications can’t simply hop to a pharmacy far away. A disabled veteran with hearing challenges can’t afford to spend an hour sorting out a prescription issue. Parents of children with developmental disabilities rely on pharmacists who understand their families and can communicate important medication details directly.
Proximity isn’t just about convenience for those with disabilities; it’s about continuity, safety, and in some cases, survival.
As a former teacher and now involved in disability policy, I’ve come to see that true service is rooted in presence. It’s essential to know the person you’re serving. This is true across diverse fields, whether you’re a banker solving a payment issue or a pastor supporting community members. Relationships matter.
Pharmacists are no different. Their roles cannot be filled by apps or call centers; their effectiveness hinges on knowing their patients personally and being present for them.
Consequences of Closing Pharmacies
Picture this: a cancer patient needs to drive 20 miles for treatment because their local pharmacy is no longer open due to a state ban.
Think about telling a parent managing a child’s seizure medications that their pharmacy has closed, forcing them to start over somewhere else.
Or imagine a stroke survivor who now doesn’t drive being told time is running out. For many individuals with disabilities, those extra minutes can mean the difference between independence and crisis.
Pharmacies do more than dispense medications. They supervise complex treatment plans, detect harmful drug interactions, and provide necessary supplements when self-management is difficult. They offer immediate assistance and guidance when something feels wrong. They maintain a calming presence that no software can replicate.
While lawmakers state their intentions to help, they’re overlooking one key need for Americans with disabilities: ensuring that their local pharmacies remain open and stable.
Access to Care Is at Risk
Drug prices in the U.S. are notoriously high. Those with disabilities often feel the strain more acutely, as they tend to use medications more frequently and for extended periods. Many rely on mail-order services, but are already experiencing delays and shortages.
Thus, policymakers must work towards lowering prices and demand more transparency from pharmacy benefit managers so patients know what they are paying. Pressure needs to be put on drug companies to create pricing structures that prioritize consumers rather than solely shareholders.
Yet, all of this is moot if the essential pharmacies that people with disabilities depend on are either regulated out of existence or shut down.
It’s vital for leaders to grasp that drug prices are high, access is weak, and for Americans with disabilities, these issues are intertwined. Vulnerable individuals can’t be effectively supported through measures that make it harder to connect with local healthcare providers. To genuinely protect patients, states need to foster an environment where pharmacies can thrive, ensuring the communities that depend on them can do the same.
